GRAIL, Inc. (GRAL)
79.31
-3.23
(-3.91%)
USD |
NASDAQ |
Aug 26, 15:27
GRAIL Market Cap : 3.542B for Aug. 26, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 25, 2026 | 3.687B |
| August 24, 2026 | 3.421B |
| August 21, 2026 | 3.553B |
| August 20, 2026 | 3.483B |
| August 19, 2026 | 3.304B |
| August 18, 2026 | 3.166B |
| August 17, 2026 | 3.124B |
| August 14, 2026 | 3.031B |
| August 13, 2026 | 3.048B |
| August 12, 2026 | 3.079B |
| August 11, 2026 | 3.371B |
| August 10, 2026 | 3.343B |
| August 07, 2026 | 3.103B |
| August 06, 2026 | 2.832B |
| August 05, 2026 | 3.313B |
| August 04, 2026 | 3.247B |
| August 03, 2026 | 3.139B |
| July 31, 2026 | 2.820B |
| July 30, 2026 | 2.926B |
| July 29, 2026 | 2.610B |
| July 28, 2026 | 2.650B |
| July 27, 2026 | 2.747B |
| July 24, 2026 | 2.791B |
| July 23, 2026 | 2.894B |
| July 22, 2026 | 2.907B |
| Date | Value |
|---|---|
| July 21, 2026 | 2.991B |
| July 20, 2026 | 2.835B |
| July 17, 2026 | 2.987B |
| July 16, 2026 | 2.960B |
| July 15, 2026 | 3.059B |
| July 14, 2026 | 3.008B |
| July 13, 2026 | 2.953B |
| July 10, 2026 | 2.962B |
| July 09, 2026 | 3.118B |
| July 08, 2026 | 2.885B |
| July 07, 2026 | 2.830B |
| July 06, 2026 | 2.836B |
| July 02, 2026 | 2.843B |
| July 01, 2026 | 2.802B |
| June 30, 2026 | 2.808B |
| June 29, 2026 | 2.813B |
| June 26, 2026 | 2.712B |
| June 25, 2026 | 2.738B |
| June 24, 2026 | 2.656B |
| June 23, 2026 | 2.514B |
| June 22, 2026 | 2.554B |
| June 18, 2026 | 2.622B |
| June 17, 2026 | 2.445B |
| June 16, 2026 | 2.398B |
| June 15, 2026 | 2.460B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 12.55B |
| Oncolytics Biotech, Inc. | 106.57M |
| Sangamo Therapeutics, Inc. | 61.69M |
| Sarepta Therapeutics, Inc. | 1.970B |
| Anixa Biosciences, Inc. | 121.78M |
Market Cap Related Metrics
| PS Ratio | 19.27 |
| Price to Book Value | 1.393 |
| Price | 79.31 |
| Earnings Yield | -12.29% |